NCT05286294View on ClinicalTrials.gov

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

March 31, 2034

Study Completion Date

December 31, 2034

Conditions
Melanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell CarcinomaMSI-HighClear Cell Renal Cell CarcinomaNon-small Cell Lung Cancer
Interventions
BIOLOGICAL

Fecal Microbiota Transplant (FMT)

Fecal Microbiota Transplant (FMT)

Trial Locations (1)

0379

Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER